Showing results (91-100 of 456) with videos related to

Sort By:
Pageof 46
Dermatology Online Journal|February 12, 2020
Melanoma in individuals with neurofibromatosis type 1: a retrospective studyMay Zhang, Trisha Bhat, David H Gutmann, et al.
Familial Cancer|December 20, 2014
Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry InitiativeQian Liu, Nancy Zoellner, David H Gutmann, et al.
Annals of Neurology|April 5, 2008
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complexLing-Hui Zeng, Lin Xu, David H Gutmann, et al.
Neurology. Genetics|September 29, 2017
Children with 5'-end NF1 gene mutations are more likely to have gliomaCorina Anastasaki, Stephanie M Morris, Feng Gao, et al.
Frontiers in Oncology|January 10, 2017
Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade GliomaCora A Ricker, Yuan Pan, David H Gutmann, et al.
Neuroimage|March 27, 2007
Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivoDebasish Banerjee, Balazs Hegedus, David H Gutmann, et al.
American Journal of Medical Genetics. Part A|September 5, 2003
Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcomeAllison King, Robert Listernick, Joel Charrow, et al.
Annals of Neurology|March 28, 2007
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendationsRobert Listernick, Rosalie E Ferner, Grant T Liu, et al.
Cancer Research|June 5, 2003
The 43000 growth-associated protein functions as a negative growth regulator in gliomaZhi-Yong Huang, YanLi Wu, Stephen P Burke, et al.
Annals of Neurology|August 5, 2004
Functional significance of S6K overexpression in meningioma progressionEzequiel I Surace, Eriks Lusis, Carrie A Haipek, et al.
Pageof 46